001     154695
005     20240229123109.0
024 7 _ |a 10.1136/bmjopen-2019-033941
|2 doi
024 7 _ |a pmid:32350013
|2 pmid
024 7 _ |a 2044-6055
|2 ISSN
024 7 _ |a 2053-3624
|2 ISSN
024 7 _ |a 2398-595X
|2 ISSN
024 7 _ |a altmetric:80879144
|2 altmetric
037 _ _ |a DKFZ-2020-00953
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Kartschmit, Nadja
|0 0000-0002-5756-5542
|b 0
245 _ _ |a Walkability and its association with walking/cycling and body mass index among adults in different regions of Germany: a cross-sectional analysis of pooled data from five German cohorts.
260 _ _ |a London
|c 2020
|b BMJ Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1627904936_25572
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a To examine three walkability measures (points of interest (POI), transit stations and impedance (restrictions to walking) within 640 m of participant's addresses) in different regions in Germany and assess the relationships between walkability, walking/cycling and body mass index (BMI) using generalised additive models.Five different regions and cities of Germany using data from five cohort studies.For analysing walking/cycling behaviour, there were 6269 participants of a pooled sample from three cohorts with a mean age of 59.2 years (SD: 14.3) and of them 48.9% were male. For analysing BMI, there were 9441 participants of a pooled sample of five cohorts with a mean age of 62.3 years (SD: 12.8) and of them 48.5% were male.(1) Self-reported walking/cycling (dichotomised into more than 30 min and 30 min and less per day; (2) BMI calculated with anthropological measures from weight and height.Higher impedance was associated with lower prevalence of walking/cycling more than 30 min/day (prevalence ratio (PR): 0.95; 95% CI 0.93 to 0.97), while higher number of POI and transit stations were associated with higher prevalence (PR 1.03; 95% CI 1.02 to 1.05 for both measures). Higher impedance was associated with higher BMI (ß: 0.15; 95% CI 0.04 to 0.25) and a higher number of POI with lower BMI (ß: -0.14; 95% CI -0.24 to 0.04). No association was found between transit stations and BMI (ß: 0.005, 95% CI -0.11 to 0.12). Stratified by cohort we observed heterogeneous associations between BMI and transit stations and impedance.We found evidence for associations of walking/cycling with walkability measures. Associations for BMI differed across cohorts.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Sutcliffe, Robynne
|b 1
700 1 _ |a Sheldon, Mark Patrick
|b 2
700 1 _ |a Moebus, Susanne
|b 3
700 1 _ |a Greiser, Karin Halina
|0 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b
|b 4
|u dkfz
700 1 _ |a Hartwig, Saskia
|b 5
700 1 _ |a Thürkow, Detlef
|b 6
700 1 _ |a Stentzel, Ulrike
|b 7
700 1 _ |a van den Berg, Neeltje
|b 8
700 1 _ |a Wolf, Kathrin
|b 9
700 1 _ |a Maier, Werner
|b 10
700 1 _ |a Peters, Annette
|b 11
700 1 _ |a Ahmed, Salman
|b 12
700 1 _ |a Köhnke, Corinna
|b 13
700 1 _ |a Mikolajczyk, Rafael
|b 14
700 1 _ |a Wienke, Andreas
|b 15
700 1 _ |a Kluttig, Alexander
|b 16
700 1 _ |a Rudge, Gavin
|b 17
773 _ _ |a 10.1136/bmjopen-2019-033941
|g Vol. 10, no. 4, p. e033941 -
|0 PERI:(DE-600)2599832-8
|n 4
|p e033941
|t BMJ open
|v 10
|y 2020
|x 2044-6055
909 C O |p VDB
|o oai:inrepo02.dkfz.de:154695
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Open peer review
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC (No Version)
|0 LIC:(DE-HGF)CCBYNCNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21